Treatment of community-acquired pneumonia in children: optimization of antibiotic therapy

Dudnyk, V.; Sinchuk, N.; Khromykh, K.

dc.contributor.author	Dudnyk, V.	en
dc.contributor.author	Sinchuk, N.	en
dc.contributor.author	Khromykh, K.	en
dc.date.accessioned	2022-01-27T09:13:04Z
dc.date.available	2022-01-27T09:13:04Z
dc.date.issued	2020
dc.identifier.citation	Dudnyk V. Treatment of community-acquired pneumonia in children: optimization of antibiotic therapy / V. Dudnyk, N. Sinchuk, K. Khromykh // Грааль науки : міжнародний журнал. - 2021. - № 1. - С. 442-448.	en
dc.identifier.uri	https://dspace.vnmu.edu.ua/123456789/5558
dc.description.abstract	Pneumonia is one of the most common diseases in children, and one of those that can cause many complications and even death. Accordingly, the treatment of this disease should be maximally effective and short-lived. The best choice for treating pneumonia is a group of oral aminopenicillins, whichwere administered in the first days of the disease and showed significantly better results than patients treated with cephalosporins.	uk_UA
dc.language.iso	en	en
dc.subject	community-acquired pneumonia	en
dc.subject	children	en
dc.subject	antibiotic therapy	en
dc.title	Treatment of community-acquired pneumonia in children: optimization of antibiotic therapy	en
dc.type	Article	en